14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $76.39 Friday, 3rd May 2024 AXSM stock ended at $74.80. This is 0.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.64% from a day low at $74.36 to a day high of $76.32.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Nov 05, 2021 $40.67 $41.25 $39.50 $40.20 801 783
Nov 04, 2021 $41.43 $42.18 $40.51 $40.85 572 829
Nov 03, 2021 $39.11 $41.61 $39.00 $41.05 754 090
Nov 02, 2021 $39.36 $40.56 $38.70 $39.55 480 968
Nov 01, 2021 $38.57 $41.35 $38.29 $39.68 875 901
Oct 29, 2021 $39.97 $40.81 $38.10 $38.50 560 653
Oct 28, 2021 $39.04 $41.22 $38.85 $39.64 633 262
Oct 27, 2021 $39.54 $40.35 $38.55 $39.24 485 768
Oct 26, 2021 $39.38 $40.11 $38.50 $39.69 425 723
Oct 25, 2021 $40.02 $40.98 $38.91 $39.29 608 649
Oct 22, 2021 $40.05 $40.68 $38.62 $40.10 484 661
Oct 21, 2021 $41.93 $42.39 $39.71 $40.82 793 847
Oct 20, 2021 $40.41 $42.50 $39.91 $41.91 641 168
Oct 19, 2021 $41.16 $41.89 $39.82 $40.18 564 599
Oct 18, 2021 $39.80 $41.26 $37.23 $41.12 1 233 551
Oct 15, 2021 $40.62 $41.97 $39.81 $40.10 644 288
Oct 14, 2021 $41.63 $42.42 $39.57 $40.62 1 549 678
Oct 13, 2021 $38.65 $42.83 $37.63 $42.17 1 881 813
Oct 12, 2021 $32.60 $37.80 $32.27 $37.79 1 395 879
Oct 11, 2021 $32.20 $33.00 $31.94 $32.62 621 320
Oct 08, 2021 $31.74 $32.64 $31.63 $32.20 566 652
Oct 07, 2021 $31.67 $32.45 $30.50 $31.74 511 650
Oct 06, 2021 $31.30 $31.64 $30.10 $30.85 662 985
Oct 05, 2021 $33.00 $34.00 $30.78 $31.33 1 791 923
Oct 04, 2021 $34.22 $34.74 $32.23 $32.63 881 548
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT